The global Diamond-Blackfan Anemia (DBAAASE) Syndrome therapeutics industry size is set to witness remarkable growth, with projections indicating a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033. The industry size is expected to surpass an impressive US$ 4.8 billion in 2023 and is anticipated to reach a value of US$ 7.29 billion …